FedCircuitBlog

• Federal Circuit Judge Calls High Court IP Decisions “Inconsistent” – At a conference on Thursday, Judge Raymond Chen noted that the Supreme Court’s policy towards novelty in the patent-eligibility inquiry seemed to be at odds with the Court’s decisions.
• Intel Trial Will Stay in Waco as Federal Circuit Declines to Weigh in – Judge Alan Albright will be able to hear the case involving VLSI Technology and Intel in Waco in February after the Federal Circuit’s decision in In re Intel Corp.
• Iancu Leaves Pro-Patentee Legacy as USPTO Director – Andrei Iancu stepped down on Wednesday after three years of instituting policies that favored patentees and that clarified USPTO procedures.

Here’s the latest.

• PTAB Axes 2 Uniloc Patents, Trims Another In Tech Giant Row – The Patent Trial and Appeal Board handed down three decisions invalidating Uniloc patents under the theory that the patent claims were obvious.
• U.S. Supreme Court rebuffs Merck appeal in hepatitis C patent fight with Gilead – The Supreme Court declined to revive a $2.54 billion jury verdict for Merck after the Federal Circuit found that Merck’s patent claims concerning a family of compounds used to treat hepatitis C were overly broad.
• Fed. Circ. Won’t Undo PTAB Rulings On Motorola Patents – On Tuesday, in a trio of unanimous opinions, the Federal Circuit affirmed the Patent Trial and Appeal Board’s decisions that upheld Motorola patents.

• Federal Circuit Patent Decisions In 2020: An Empirical Review – Dan Bagatell issues his fourth review of the Federal Circuit’s patent decisions of the past year.
• Boom! You Can’t Patent an Escrow Method – The Federal Circuit recently affirmed the dismissal of Boom! Payments’ claim due to a lack of patent eligibility.
• Nintendo’s Win in Wii Controller Patent Case Affirmed – Nintendo’s avoidance of a $10 million infringement award stands after the Federal Circuit affirmed the lower court’s decision in iLife Technologies, Inc. v. Nintendo of America, Inc..

Here’s the latest.

• ITC Cases Mean No Agency Patent Review for Nintendo, SK Innovation – Applying the NHK-Fintiv factors, the Patent Trial and Review Board refused to review Nintendo’s challenge to a video game controller patent.
• Supreme Court Will Review Doctrine of Assignor Estoppel – The Supreme Court granted certiorari last Friday in Minerva Surgical Inc. v. Hologic Inc., on appeal from the Federal Circuit. The case asks the justices to resolve whether a defendant in a patent infringement action who assigned the patent or is in privity with an assignor of the patent, may have a defense of invalidity heard on the merits.

Here’s the latest.

• QuikTrip Fails to Block Competitor’s “Kitchen” Logo – The Federal Circuit determined that Weigel’s logo did not infringe QuikTrip’s “QT Kitchens” trademark.
• Supreme Court Will Decide if Turnabout Is Fair Play in Patent Law – The Supreme Court will determine whether the doctrine of assignor estoppel should continue in a recently granted case.
• Vaccine Act Claimant Gets Second Chance at Attorneys’ Fees – A woman will be able to pursue attorney’s fees despite an unsuccessful claim after the Federal Circuit ruled that her claim may not have been unreasonable.

Here’s the latest.

On Friday the Supreme Court granted the petition for certiorari in Minerva Surgical, Inc. v. Hologic, Inc., a patent infringement case decided by the Federal Circuit in April of last year. In this case, the petitioner asks the Court to abandon or limit the doctrine of assignor estoppel, which prevents a party who in the past assigned a patent from later contesting the patent’s validity. Here are the details.

• Federal Circuit Statistics – 2020 Edition – Jason Rantanen analyzes the data and trends in the cases heard and decided by the Federal Circuit this year.
• Gilead “Rewriting” History To Save $2.5B IP Win, Justices Told – Idenix Pharmaceuticals implored the Supreme Court to grant certiorari and reinstate the country’s largest patent verdict after the Federal Circuit reversed the lower court’s decision.
• What to Watch in 2021: IP Stakeholders Offer Predictions and Thoughts for the New Year – Several contributors shared their opinions on the state of intellectual property, the Federal Circuit, and the USPTO going forward into the new year.

Here’s the latest.

• Trademark Modernization Act Becomes Law: Establishes New Procedures to Remove Deadwood Registrations, Restores Presumption of Irreparable Harm, and Protects the Independence of the Trademark Trial and Appeal Board – The Trademark Modernization Act was signed into law on Sunday as part of a COVID-19 relief and government spending bill entitled the “Consolidated Appropriations Act, 2021.”
• One vet’s GI Bill fight could win benefits for millions of other students – A final decision from the Federal Circuit is expected soon, which may have an impact on students looking to enroll in college courses in the fall of 2021.

Here’s the latest.

• CAFC Upholds District Court Finding for Netflix Invalidating Adaptive Patent Under 101 – The Federal Circuit affirmed a district court’s finding that Adaptive Streaming Inc.’s patent claims were directed at an abstract idea and thus were invalid under 35 U.S.C. § 101.
• 3 Key Questions As Cleveland MLB Team Mulls New Name – On Monday, Major League Baseball team the Cleveland Indians announced that it is starting the process to change its name as teams continue to face pressure to drop their “disparaging monikers.”
• Employment Law and Patent Law Collide: Federal Circuit Rules that California’s Non-Compete Restrictions Also Limit the Scope of Patent and Invention Assignment Clauses – The Federal Circuit ruled that certain employment agreement provisions requiring former employees to assign their inventions to their employer after such employment ends are not permitted in California.

Here’s the latest.

• Fed. Circ. Again Says No State Sovereign Immunity In IPRs – In Board of Regents of the University of Texas System v. Baylor College of Medicine, the Federal Circuit held that plaintiffs can request inter partes reviews of state universities’ patents and sovereign immunity does not apply.
• Federal Circuit Tries to Wrap Its Arms Around Functional Biotech Patent Claims – The Federal Circuit heard oral arguments last Wednesday and focused on the application of the enablement requirement to Amgen’s patent covering therapeutic antibodies.
• Del. Chief Urges Creativity When Litigating Patent Eligibility – Chief Judge Leonard Stark addressed the resolution of patent eligibility issues within litigation during a panel discussion on Friday.

Here’s the latest.